2,771
Views
12
CrossRef citations to date
0
Altmetric
Back Matter

Endogenous and exogenous glucocorticoids abolish the efficacy of immune-dependent cancer therapies

ORCID Icon, & ORCID Icon
Article: 1673635 | Received 24 Sep 2019, Accepted 25 Sep 2019, Published online: 11 Oct 2019

References

  • Russell G, Lightman S. The human stress response. Nat Rev Endocrinol. 2019;15:525–3. doi:10.1038/s41574-019-0228-0.
  • Gonzalo JA, Gonzalez-Garcia A, Martinez C, Kroemer G. Glucocorticoid-mediated control of the activation and clonal deletion of peripheral T cells in vivo. J Exp Med. 1993;177:1239–1246. doi:10.1084/jem.177.5.1239.
  • Wick G, Hu Y, Schwarz S, Kroemer G. Immunoendocrine communication via the hypothalamo-pituitary-adrenal axis in autoimmune diseases. Endocr Rev. 1993;14:539–563. doi:10.1210/edrv-14-5-539.
  • Williams KJ, Grauer DW, Henry DW, Rockey ML. Corticosteroids for the management of immune-related adverse events in patients receiving checkpoint inhibitors. J Oncol Pharm Pract. 2019;25:544–550. doi:10.1177/1078155217744872.
  • Maxwell R, Luksik AS, Garzon-Muvdi T, Hung AL, Kim ES, Wu A, Xia Y, Belcaid Z, Gorelick N, Choi J, et al. Contrasting impact of corticosteroids on anti-PD-1 immunotherapy efficacy for tumor histologies located within or outside the central nervous system. Oncoimmunology. 2018;7:e1500108. doi:10.1080/2162402X.2018.1500108
  • Obradovic MMS, Hamelin B, Manevski N, Couto JP, Sethi A, Coissieux -M-M, Münst S, Okamoto R, Kohler H, Schmidt A, et al. Glucocorticoids promote breast cancer metastasis. Nature. 2019;567:540–544. doi:10.1038/s41586-019-1019-4.
  • Galluzzi L, Kroemer G. Cancer cells thrive on stress. Trends Cell Biol. 2019;29:447–449. doi:10.1016/j.tcb.2019.03.005.
  • Yang H, Xia L, Chen J, Zhang S, Martin V, Li Q, Lin S, Chen J, Calmette J, Lu M, et al. Stress-glucocorticoid-TSC22D3 axis compromises therapy-induced antitumor immunity. Nat Med. 2019;25:1428–1441. doi:10.1038/s41591-019-0566-4.
  • Falcon-Beas C, Tittarelli A, Mora-Bau G, Tempio F, Pérez C, Hevia D, Behrens C, Flores I, Falcón-Beas F, Garrido P, et al. Dexamethasone turns tumor antigen-presenting cells into tolerogenic dendritic cells with T cell inhibitory functions. Immunobiology. 2019;224:697–705. doi:10.1016/j.imbio.2019.05.011.
  • Draghi A, Borch TH, Radic HD, Chamberlain CA, Gokuldass A, Svane IM, Donia M. Differential effects of corticosteroids and anti-TNF on tumor-specific immune responses: implications for the management of irAEs. Int J Cancer. 2019;145:1408–1413. doi:10.1002/ijc.32080.